Can your smartwatch help your heart doctor?
NCT ID NCT06595615
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study enrolls 80 people with implanted heart devices to see if collecting extra health data from wearables and a phone app can improve care. Participants must have had a heart failure event in the past year. The goal is simply to gather data, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that wearable data helps doctors better monitor heart patients and predict problems.
- What could go wrong
- This is a small feasibility study, not testing a treatment. It may not lead to any direct health improvements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients indicated for cardiac implantable medical devices
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients are willing to be compliant with daily measurements required 18 years of age or older * Patients who have been implanted with ABT CRT-D devices connected to Merlin.net * Patients who had at least one HF clinical event during past 12 calendar months * Must provide written informed consent prior to the commencement of this clinical feasibility study * Patients are willing to be compliant with daily measurements required Exclusion Criteria: * Pregnant and/or lactating mothers will be excluded from the study or have a plan to be pregnant in the next 12 months * Patients with a life expectancy less than the duration of the study, as per clinician's discretion. * Patients who will not be able to complete the daily survey questions due to inability to read
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Heart Center Research
Huntsville, Alabama, 35801, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?